These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9284295)

  • 21. The molecular pathology of Alzheimer's disease.
    Harrington CR
    Neuroimaging Clin N Am; 2012 Feb; 22(1):11-22, vii. PubMed ID: 22284730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease: β-amyloid plaque formation in human brain.
    Seeman P; Seeman N
    Synapse; 2011 Dec; 65(12):1289-97. PubMed ID: 21633975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How Anticholinergic Drugs Might Promote Alzheimer's Disease: More Amyloid-β and Less Phosphatidylcholine.
    Wurtman RJ
    J Alzheimers Dis; 2015; 46(4):983-7. PubMed ID: 26402628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain-membrane cholesterol in Alzheimer's disease.
    Eckert GP; Kirsch C; Müller WE
    J Nutr Health Aging; 2003; 7(1):18-23. PubMed ID: 12679836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotransmitters and energy metabolites in amyloid-bearing APP(SWE)xPSEN1dE9 Mouse Brain.
    Hartmann J; Kiewert C; Klein J
    J Pharmacol Exp Ther; 2010 Feb; 332(2):364-70. PubMed ID: 19846589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biochemistry of alzheimer's disease].
    Hasegawa N; Ihara Y
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):119-23. PubMed ID: 1673700
    [No Abstract]   [Full Text] [Related]  

  • 31. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta.
    Salkovic-Petrisic M; Osmanovic J; Grünblatt E; Riederer P; Hoyer S
    J Alzheimers Dis; 2009; 18(4):729-50. PubMed ID: 19661616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurobiology and molecular biology of Alzheimer's disease].
    DeKosky ST
    Rev Neurol; 2002 Oct 16-31; 35(8):752-60. PubMed ID: 12402229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
    Joachim CL; Mori H; Selkoe DJ
    Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cell biological perspective on Alzheimer's disease.
    Annaert W; De Strooper B
    Annu Rev Cell Dev Biol; 2002; 18():25-51. PubMed ID: 12142279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging enhances vascular dysfunction induced by the Alzheimer's peptide beta-amyloid.
    Price JM; Hellermann A; Hellermann G; Sutton ET
    Neurol Res; 2004 Apr; 26(3):305-11. PubMed ID: 15142324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choline-containing phospholipids: relevance to brain functional pathways.
    Tayebati SK; Amenta F
    Clin Chem Lab Med; 2013 Mar; 51(3):513-21. PubMed ID: 23314552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choline plus cytidine stimulate phospholipid production, and the expression and secretion of amyloid precursor protein in rat PC12 cells.
    Wang CS; Lee RK
    Neurosci Lett; 2000 Mar; 283(1):25-8. PubMed ID: 10729625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.